Edesa Biotech, Inc. — Director's Dealing 2019

Jun 11, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edesa Biotech, Inc. (EDSA)
CIK: 0001540159
Period of Report: 2019-06-07

Reporting Person: MacDonald Sean Arthur (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-06-07	Common Shares	A	13583	—	Acquired	13583	Direct

Footnotes

F1: Represents common shares of Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.)(the "Issuer") issued in the share exchange transaction that was completed on June 7, 2019, pursuant to that certain Share Exchange Agreement, dated March 7, 2019, by and among the Issuer, Edesa Biotech Inc. and the shareholders of Edesa Biotech Inc. All share numbers reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019.